截至2024年底 全国医疗卫生机构总量已达到 109万所,超过90%的 居民在15分钟内能够 到达最近的医疗服务点 2024年互联网医院 诊疗人次达到１.３亿 截至2025年8月 全国有338个地市（州、盟） 互认医学检查化学项目超过200项 全国81个城市的紧密型城市医疗 集团正在试点推进中,2199个 县区开展了紧密型县域医共体建设 截至2024年底 全国设有1个国家老年医学中心和 6个国家老年疾病临床医学研究中心, 设有老年医学科的二级以上 综合医院达到6151家 儿科执业（ 助理 ）医师的数量 达到24.39万人,比2020年的 16.34万人增长了49.3% 我国已建成世界上规模最大的医疗服务体系和疾病预防控制体系，居民健康水平持续提升。9月11日， 国务院新闻办举行"高质量完成'十四五'规划"系列主题新闻发布会，介绍"十四五"时期卫生健康工作发 展成就。 努力解决人民群众看病就医的急难愁盼问题 国家卫生健康委主任雷海潮说，"十四五"时期，按照"大病不出省，一般病在市县解决，日常疾病在基 层解决"的工作目标，我国努力解决人民群众看病就医的急难愁盼问题，面向居民提供全方位、全周期 的健康服务。 优化医 ...

本报北京9月11日电(记者王美华)国务院新闻办公室11日举行"高质量完成'十四五'规划"系列主题新闻发 布会，国家卫生健康委主任雷海潮在会上介绍，"十四五"时期，我国卫生健康服务的能力水平、可及 性、公平性得到持续改善和提升，群众健康水平也得到持续改善。据统计，2024年我国居民人均预期寿 命达到79岁，比2020年提高1.1岁，有8个省份人均预期寿命超过80岁，居民健康水平稳步提高。 "我们建成世界上规模最大的医疗服务体系，服务质量和效率得到双提升。"雷海潮介绍，我国持续推进 医疗资源下沉和均衡布局，推动建设国家医学中心、国家区域医疗中心和省级区域医疗中心建设，服务 可及性、服务水平都得到提高。据监测，东中西部千人口医疗资源差距正在不断缩小。 过去5年，国家卫生健康委全面推进紧密型县域医共体建设，医疗机构间的协同协作关系得到进一步加 强。据统计，到2024年底，全国医疗卫生机构总量已经达到109万所，超过90%的居民在15分钟内能够 到达最近的医疗服务点。 "卫生服务人力资源不断扩增，到去年年底已达到1578万人，这为老百姓提供更好的卫生健康服务创造 了良好条件。"雷海潮说，我国大量开展微创手术、日间手术， ...

Core Viewpoint - The press conference highlighted the achievements in health and wellness during the "14th Five-Year Plan" period, showcasing the development of China's healthcare system and policies aimed at improving public health and supporting families. Group 1: Healthcare System Development - China has established the world's largest healthcare service system, with a total of 1.09 million medical institutions and 15.78 million health workers by the end of 2024 [2] - The number of grassroots healthcare institutions increased from 970,000 to 1.04 million from 2020 to 2024, with annual medical service visits rising from 4.1 billion to 5.3 billion [3] - Basic medical insurance now covers over 1.3 billion residents, maintaining a coverage rate of around 95% [4] Group 2: Disease Prevention and Control - China has built the world's largest disease prevention and control system, enhancing grassroots health governance and establishing a four-tier disease prevention network [6] - The government provides immunization services for 15 diseases, and the early mortality rate from major chronic diseases has been further controlled [6] Group 3: Pharmaceutical Innovation - China accounts for over 20% of the global new drug research and development, ranking second worldwide [7] - Several domestic innovative drugs, including Sugliatin, Ensatinib, and Gumeitini, have been approved for market release, filling gaps in their respective fields [7] - The domestically developed anti-tumor drug Zebutinib has been approved in multiple countries [8] Group 4: Family Support Policies - A series of family support policies have been implemented during the "14th Five-Year Plan," including tax deductions for childcare and education, with a monthly deduction standard raised to 2,000 yuan per child [9] - As of September 10, over 24 million applications for childcare subsidies have been submitted, covering about 80% of the target population [10] - Various provinces have extended maternity leave and established paternity leave and parental leave [11] Group 5: Education and Housing Support - Efforts to expand quality educational resources and reduce preschool education fees have been made, along with policies to facilitate transportation for families with multiple children [11] - Housing support measures include increasing the loan limits for housing provident funds for families with multiple children [12] Group 6: Health Initiatives for Women and Children - The domestically developed HPV vaccine is now widely used, with the nine-valent HPV vaccine recently introduced [13] - The government will launch HPV vaccination services for eligible girls and include the vaccine in the national immunization program [14] - Improvements in children's health are noted, with a decrease in the obesity rate among children under six from 10.4% to 9.7% over five years [14]